MSLN and neoplasm: With high expression of RIAD and CXCR3, MesoCAR-RIAD T cells show an enhanced trafficking and infiltration ability compared with mesoCAR T cells and exhibit enhanced tumor killing ability against mesothelin positive tumor cells (Fig. 3A) [33].